Search

Author/Creator Robb, Stephen

1. Efficacy and Safety of Bevacizumab-Containing Therapy in Newly Diagnosed Ovarian Cancer: ROSiA Single-Arm Phase 3B Study. Issue 1 (1st January 2016)

Authors:
Oza, Amit M.; Selle, Frédéric; Davidenko, Irina; Korach, Jacob; Mendiola, Cesar; Pautier, Patricia; Chmielowska, Ewa; Bamias, Aristotelis; DeCensi, Andrea; Zvirbule, Zanete; González-Martín, Antonio; Hegg, Roberto; Joly, Florence; Zamagni, Claudio; Gadducci, Angiolo; Martin, Nicolas; Robb, Stephe...
Journal:
International journal of gynecological cancer
Issue:
Volume 27:Issue 1(2017)
Page Start:
50
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy and Safety of Bevacizumab-Containing Therapy in Newly Diagnosed Ovarian Cancer: ROSiA Single-Arm Phase 3B Study. Issue 1 (January 2017)

Authors:
Oza, Amit M.; Selle, Frédéric; Davidenko, Irina; Korach, Jacob; Mendiola, Cesar; Pautier, Patricia; Chmielowska, Ewa; Bamias, Aristotelis; DeCensi, Andrea; Zvirbule, Zanete; González-Martín, Antonio; Hegg, Roberto; Joly, Florence; Zamagni, Claudio; Gadducci, Angiolo; Martin, Nicolas; Robb, Stephe...
Journal:
International journal of gynecological cancer
Issue:
Volume 27:Issue 1(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Effects of the P‐Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention According to Timing of Infusion: Insights From the SELECT‐ACS Trial. Issue 11 (16th November 2016)

Authors:
Stähli, Barbara E.; Gebhard, Catherine; Duchatelle, Valérie; Cournoyer, Daniel; Petroni, Thibaut; Tanguay, Jean‐François; Robb, Stephen; Mann, Jessica; Guertin, Marie‐Claude; Wright, R. Scott; L. L'Allier, Philippe; Tardif, Jean‐Claude
Journal:
Journal of the American Heart Association
Issue:
Volume 5:Issue 11(2016)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Effects of the P‐Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention According to Timing of Infusion: Insights From the SELECT‐ACS Trial. Issue 11 (November 2016)

Authors:
Stähli, Barbara E.; Gebhard, Catherine; Duchatelle, Valérie; Cournoyer, Daniel; Petroni, Thibaut; Tanguay, Jean‐François; Robb, Stephen; Mann, Jessica; Guertin, Marie‐Claude; Wright, R. Scott; L. L'Allier, Philippe; Tardif, Jean‐Claude
Journal:
Journal of the American Heart Association
Issue:
Volume 5:Issue 11(2016)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗